Medicine composition for treating backbone and joint disease

A joint disease and composition technology, applied in the field of pharmaceutical compositions, can solve problems such as difficult treatment, cumbersome treatment procedures, and long treatment time

Inactive Publication Date: 2006-10-25
周福阳
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] In order to solve the problems of difficult treatment, cumbersome treatment procedures, long treatment time and unsatisfactory treatment effect in the current treatment o...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] The components that the pharmaceutical composition that present embodiment adopts comprises and the parts by weight of each component are as follows:

[0032] 900 parts of isinglass, 30 parts of papaya, 180 parts of angelica, 30 parts of cinnamon, 60 parts of Wujia skin, 180 parts of sand garden seed, 180 parts of rehmannia glutinosa, 180 parts of Polygonatum odoratum, 120 parts of Eucommia ulmoides, 100 parts of turtle plate, 60 parts of cistanche , 180 parts of Achyranthes bidentata, 180 parts of Shenjincao, 60 parts of drynaria, 60 parts of dodder, 60 parts of gallinaceae, 30 parts of Panax notoginseng, and 180 parts of Baji.

[0033] The preparation method of the present embodiment pharmaceutical composition is as follows:

[0034] Each component is weighed according to the above parts by weight, ground and pulverized, mixed, and prepared into capsules according to conventional pharmaceutical methods, each 0.5 g.

[0035] Clinical patient statistics: 98 patients we...

Embodiment 2

[0039]The components that the pharmaceutical composition that present embodiment adopts comprises and the parts by weight of each component are as follows:

[0040] 700 parts of isinglass, 50 parts of papaya, 150 parts of angelica, 50 parts of cinnamon, 40 parts of Wujiapi, 210 parts of shayuanzi, 150 parts of rehmannia glutinosa, 210 parts of Polygonatum ulmoides, 100 parts of Eucommia, 120 parts of turtle plate, 40 parts of cistanche , 210 parts of Achyranthes bidentata, 150 parts of Shenjincao, 80 parts of drynaria, 40 parts of dodder, 80 parts of gallinaceous gold, 20 parts of Panax notoginseng, and 210 parts of Baji.

[0041] The preparation method of the present embodiment pharmaceutical composition is as follows:

[0042] Each component is weighed according to the above parts by weight, ground and pulverized, mixed, prepared into a powder according to a conventional pharmaceutical method, and divided into bottles, 12 grams per bottle.

[0043] Statistics of clinical pa...

Embodiment 3

[0047] The components that the pharmaceutical composition that present embodiment adopts comprises and the parts by weight of each component are as follows:

[0048] 1100 parts of isinglass, 10 parts of papaya, 210 parts of angelica, 10 parts of cinnamon, 80 parts of Wujiapi, 150 parts of shayuanzi, 210 parts of Rehmannia glutinosa, 150 parts of Polygonatum odoratum, 140 parts of Eucommia, 80 parts of turtle plate, 80 parts of cistanche , 150 parts of Achyranthes bidentata, 210 parts of Shenjincao, 40 parts of drynaria, 80 parts of dodder, 40 parts of gallinaceous gold, 40 parts of panax notoginseng, and 150 parts of Baji.

[0049] The preparation method of the present embodiment pharmaceutical composition is as follows:

[0050] Each component was weighed according to the above parts by weight, ground and pulverized, mixed, and prepared into pills according to conventional pharmaceutical methods, each pill 9 grams.

[0051] Clinical patient statistic: the patient that applie...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a Chinese medicine composition for effectively curing the diseases of prolapse of lumbar intervertebral disk, cervical spondylopathy, spur, hyperosteogeny, hypertrophic arthritis and osteoarthrosis deformans endemica, etc. Said Chinese medicine composition is formed from 17 Chinese medicinal materials of fish glue, Chinese angelica root, cinnamon bark chaenomeles fruit, acanthopanax root bark, cooked rehmannia root, notoginseng and others.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating spinal and joint diseases. Background technique [0002] The incidence rate of cervical, lumbar and joint diseases in my country is as high as 15.9%, and there is an increasing trend year by year, which is seriously infringing on the health of middle-aged and elderly people and office workers. [0003] Cervical spondylosis, also known as cervical syndrome, is common in middle-aged and elderly people. It is caused by the gradual degeneration of the cervical intervertebral disc, hyperosteogeny of the cervical spine, or changes in the normal physiological curve of the cervical spine that stimulate or compress the cervical nerve root, cervical spinal cord, and vertebral artery. , Syndrome caused by cervical sympathetic nerve. Such patients often feel numbness in the head, neck, shoulders and arms in mild cases, and in severe cases can lead to ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8969A61K9/14A61K9/20A61K9/48A61K35/57A61K35/586A61K35/60A61P19/02A61P19/08A61P29/00
Inventor 周福阳刘庆贺
Owner 周福阳
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap